Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 46, 2014, Pages E5007-E5015

  Zhang, Hai Ying ^a   Gao, Ming ^b   Liu, Qing Rong ^a   Bi, Guo Hua ^a   Li, Xia ^c   Yang, Hong Ju ^a   Gardner, Eliot L ^a   Wu, Jie ^b,d,e   Xi, Zheng Xiong ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; CANNABINOID 2 RECEPTOR; COCAINE; MESSENGER RNA; 1,1-DIMETHYLBUTYL-1-DEOXY-DELTA(9)-THC; CANNABINOID; CANNABINOID 1 RECEPTOR; DOPAMINE; INDOLE DERIVATIVE; IODOPRAVADOLINE; NERVE PROTEIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; EX VIVO STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MALE; MESENCEPHALON; MOUSE; NERVE CONDUCTION; NERVE EXCITABILITY; NONHUMAN; VENTRAL TEGMENTUM; ACTION POTENTIAL; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; APPETITE; C57BL MOUSE; COCAINE DEPENDENCE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; DRUG SELF ADMINISTRATION; FEEDING BEHAVIOR; GENETICS; GLIA; KNOCKOUT MOUSE; METABOLISM; MICROINJECTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REWARD; SPLEEN;

MUS;

ACTION POTENTIALS; ANIMALS; APPETITIVE BEHAVIOR; CANNABINOIDS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE; DOPAMINERGIC NEURONS; FEEDING BEHAVIOR; INDOLES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROINJECTIONS; NERVE TISSUE PROTEINS; NEUROGLIA; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REWARD; RNA, MESSENGER; SELF ADMINISTRATION; SPLEEN; VENTRAL TEGMENTAL AREA;

EID: 84915754556     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1413210111     Document Type: Article

References (58)

1. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365(6441):61-65.
2. Galiègue S, et al. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232(1): 54-61.
3. Griffin G, et al. (1999) Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: Further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol 377(1):117-125.
4. Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE (1997) Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142(2):278-287.
5. McCoy KL, Matveyeva M, Carlisle SJ, Cabral GA (1999) Cannabinoid inhibition of the processing of intact lysozyme by macrophages: Evidence for CB2 receptor participation. J Pharmacol Exp Ther 289(3):1620-1625.
6. Buckley NE, et al. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 396(2-3):141-149.
7. Lu Q, Straiker A, Lu Q, Maguire G (2000) Expression of CB2 cannabinoid receptor mRNA in adult rat retina. Vis Neurosci 17(1):91-95.
8. Skaper SD, et al. (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 93(9):3984-3989.
9. Lanciego JL, et al. (2011) Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis. J Psychopharmacol 25(1):97-104.
10. Liu QR, et al. (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): Identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav 8(5): 519-530.
11. Garcia-Gutierrez MS, Garcia-Bueno B, Zoppi S, Leza JC, Manzanares J (2011) Chronic blockade of cannabinoid CB(2) receptors induces anxiolytic-like actions associated to alterations in GABA(A) receptors. Br J Pharmacol 165(4):951-64.
12. Navarrete F, Pérez-Ortiz JM, Manzanares J (2012) Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice. Br J Pharmacol 165(1): 260-273.
13. Van Sickle MD, et al. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310(5746):329-332.
14. Viscomi MT, et al. (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci 29(14):4564-4570.
15. Ashton JC, Friberg D, Darlington CL, Smith PF (2006) Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study. Neurosci Lett 396(2):113-116.
16. Baek JH, Zheng Y, Darlington CL, Smith PF (2008) Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei. Acta Otolaryngol 128(9):961-967.
17. Brusco A, Tagliaferro P, Saez T, Onaivi ES (2008) Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62(12):944-949.
18. Gong JP, et al. (2006) Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res 1071(1):10-23.
19. Aracil-Fernández A, et al. (2012) Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB2 receptors. Neuropsychopharmacology 37(7):1749-1763.
20. Schmidt W, Schäfer F, Striggow V, Fröhlich K, Striggow F (2012) Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia. Neuroscience 227:313-326.
21. Atwood BK, Mackie K (2010) CB2: A cannabinoid receptor with an identity crisis. Br J Pharmacol 160(3):467-479.
22. Xi ZX, et al. (2011) Brain cannabinoid CB2 receptors modulate cocaine's actions in mice. Nat Neurosci 14(9):1160-1166.
23. Ignatowska-Jankowska BM, Muldoon PP, Lichtman AH, Damaj MI (2013) The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice. Psychopharmacology (Berl) 229(4):591-601.
24. García C, et al. (2011) Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease. Br J Pharmacol 163(7): 1495-1506.
25. Ortega-Alvaro A, Aracil-Fernández A, García-Gutiérrez MS, Navarrete F, Manzanares J (2011) Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 36(7):1489-1504.
26. García-Gutiérrez MS, Manzanares J (2011) Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. J Psychopharmacol 25(1):111-120.
27. García-Gutiérrez MS, Pérez-Ortiz JM, Gutiérrez-Adán A, Manzanares J (2010) Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol 160(7):1773-1784.
28. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191-225.
29. Xi ZX, Gardner EL (2008) Hypothesis-driven medication discovery for the treatment of psychostimulant addiction. Curr Drug Abuse Rev 1(3):303-327.
30. Wu J, et al. (2004) Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J Pharmacol Exp Ther 311(1):80-91.
31. Yang K, et al. (2009) Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons. J Physiol 587(Pt 2):345-361.
32. Brown RE, et al. (2008) Characterization of GABAergic neurons in rapid-eye-movement sleep controlling regions of the brainstem reticular formation in GAD67-green fluorescent protein knock-in mice. Eur J Neurosci 27(2):352-363.
33. Gao M, et al. (2010) Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area. J Neurosci 30(41):13814-13825.
34. Zhang D, et al. (2012) Impact of prefrontal cortex in nicotine-induced excitation of ventral tegmental area dopamine neurons in anesthetized rats. J Neurosci 32(36): 12366-12375.
35. Shi WX (2005) Slow oscillatory firing: A major firing pattern of dopamine neurons in the ventral tegmental area. J Neurophysiol 94(5):3516-3522.
36. Song R, et al. (2012) Increased vulnerability to cocaine in mice lacking dopamine D3 receptors. Proc Natl Acad Sci USA 109(43):17675-17680.
37. Mansour A, et al. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study. J Comp Neurol 350(3):412-438.
38. Mansour A, Fox CA, Thompson RC, Akil H, Watson SJ (1994) Mu-opioid receptor mRNA expression in the rat CNS: Comparison to mu-receptor binding. Brain Res 643(1-2):245-265.
39. Mansour A, Fox CA, Burke S, Akil H, Watson SJ (1995) Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8(4): 283-305.
40. Wang F, et al. (2012) RNAscope: A novel in situ RNA analysis platform for formalinfixed, paraffin-embedded tissues. J Mol Diagn 14(1):22-29.
41. Stella N (2010) Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58(9):1017-1030.
42. Stella N (2004) Cannabinoid signaling in glial cells. Glia 48(4):267-277.
43. Zhang J, et al. (2003) Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 17(12):2750-2754.
44. Elmes SJ, Jhaveri MD, Smart D, Kendall DA, Chapman V (2004) Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci 20(9):2311-2320.
45. Jhaveri MD, et al. (2008) Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. Eur J Neurosci 27(7):1722-1730.
46. Nackley AG, Zvonok AM, Makriyannis A, Hohmann AG (2004) Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J Neurophysiol 92(6): 3562-3574.
47. Sagar DR, et al. (2005) Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci 22(2):371-379.
48. den Boon FS, et al. (2012) Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci USA 109(9):3534-3539.
49. Morgan NH, Stanford IM, Woodhall GL (2009) Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 57(4):356-368.
50. Marinelli M, White FJ (2000) Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20(23):8876-8885.
51. Agudo J, et al. (2010) Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. Diabetologia 53(12): 2629-2640.
52. Flake NM, Zweifel LS (2012) Behavioral effects of pulp exposure in mice lacking cannabinoid receptor 2. J Endod 38(1):86-90.
53. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96(10):5780-5785.
54. Buckley NE (2008) The peripheral cannabinoid receptor knockout mice: An update. Br J Pharmacol 153(2):309-318.
55. Tamamaki N, et al. (2003) Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467(1):60-79.
56. Committee on Care and Use of Laboratory Animals (1996) Guide for the Care and Use of Laboratory Animals (Natl Inst Health, Bethesda), DHHS Publ No (NIH) 85-23.
57. Zhang D, Yang S, Jin GZ, Bunney BS, Shi WX (2008) Oscillatory firing of dopamine neurons: Differences between cells in the substantia nigra and ventral tegmental area. Synapse 62(3):169-175.
58. Gao M, et al. (2007) Functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area. J Neurosci 27(20):5414-5421.